These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31454708)

  • 41. Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi.
    Peyclit L; Yousfi H; Rolain JM; Bittar F
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34065420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections.
    Ng SMS; Sioson JSP; Yap JM; Ng FM; Ching HSV; Teo JWP; Jureen R; Hill J; Chia CSB
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):141-148. PubMed ID: 29019016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.
    Ku NS; Lee SH; Lim YS; Choi H; Ahn JY; Jeong SJ; Shin SJ; Choi JY; Choi YH; Yeom JS; Yong D; Song YG; Kim JM
    Sci Rep; 2019 Nov; 9(1):17127. PubMed ID: 31748527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
    Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
    J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
    Deveci A; Coban AY; Acicbe O; Tanyel E; Yaman G; Durupinar B
    J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug combinations: a strategy to extend the life of antibiotics in the 21st century.
    Tyers M; Wright GD
    Nat Rev Microbiol; 2019 Mar; 17(3):141-155. PubMed ID: 30683887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
    Mataracı Kara E; Yılmaz M; Özbek Çelik B
    J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae.
    Thwaites M; Hall D; Stoneburner A; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):338-345. PubMed ID: 30097297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The FICI paradigm: Correcting flaws in antimicrobial in vitro synergy screens at their inception.
    Gómara M; Ramón-García S
    Biochem Pharmacol; 2019 May; 163():299-307. PubMed ID: 30836058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug combination therapy increases successful drug repositioning.
    Sun W; Sanderson PE; Zheng W
    Drug Discov Today; 2016 Jul; 21(7):1189-95. PubMed ID: 27240777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug repurposing for bacterial infections.
    Ilyas M; Latif MS; Gul A; Babar MM; Rajadas J
    Prog Mol Biol Transl Sci; 2024; 207():1-21. PubMed ID: 38942533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.
    Montero MM; Domene Ochoa S; López-Causapé C; VanScoy B; Luque S; Sorlí L; Campillo N; Padilla E; Prim N; Segura C; Pomar V; Rivera A; Grau S; Ambrose PG; Oliver A; Horcajada JP
    J Glob Antimicrob Resist; 2019 Sep; 18():37-44. PubMed ID: 31154007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.
    Wang CH; Hsieh YH; Powers ZM; Kao CY
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
    Principe L; Capone A; Mazzarelli A; D'Arezzo S; Bordi E; Di Caro A; Petrosillo N
    Microb Drug Resist; 2013 Oct; 19(5):407-14. PubMed ID: 23659601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vitro Antibacterial Activity of Curcumin-Polymyxin B Combinations against Multidrug-Resistant Bacteria Associated with Traumatic Wound Infections.
    Betts JW; Sharili AS; La Ragione RM; Wareham DW
    J Nat Prod; 2016 Jun; 79(6):1702-6. PubMed ID: 27295561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repurposing of gallium-based drugs for antibacterial therapy.
    Bonchi C; Imperi F; Minandri F; Visca P; Frangipani E
    Biofactors; 2014; 40(3):303-12. PubMed ID: 24532037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.
    MacVane SH
    J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug repurposing to overcome microbial resistance.
    Jampilek J
    Drug Discov Today; 2022 Jul; 27(7):2028-2041. PubMed ID: 35561965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.